Effects of clozapine on behavioral sensitization induced by cocaine

Psychiatry Research

Volumn 175, Issue 1-2, 2010, Pages 165-170

  Park, Hye Jean ^a   Cui, Feng Ji ^b   Hwang, Jae Yeon ^a   Kang, Ung Gu ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

AKT; Behavioral sensitization; Clozapine; Cocaine; Cyclic AMP response element binding protein; ERK; Glycogen synthase kinase 3; Prefrontal cortex; Psychosis

Indexed keywords

CLOZAPINE; COCAINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DESENSITIZATION; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; DRUG RECHALLENGE; FRONTAL CORTEX; LOCOMOTION; MALE; MENTAL FUNCTION; MESOLIMBIC DOPAMINERGIC SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PSYCHOSIS; SENSITIZATION; TREATMENT DURATION; VIDEORECORDING;

ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CLOZAPINE; COCAINE; CREB-BINDING PROTEIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCOGEN SYNTHASE KINASE 3; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; ONCOGENE PROTEIN V-AKT; PREFRONTAL CORTEX; SIGNAL TRANSDUCTION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 72049119101     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2008.10.005     Document Type: Article

References (42)

1. Ago Y., Nakamura S., Hayashi A., Itoh S., Baba A., and Matsuda T. Effects of osemozotan, ritanserin and azasetron on cocaine-induced behavioral sensitization in mice. Pharmacology, Biochemistry and Behavior 85 (2006) 198-205
2. Ago Y., Nakamura S., Kajita N., Uda M., Hashimoto H., Baba A., and Matsuda T. Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice. Synapse 61 (2007) 757-763
3. Brenhouse H.C., and Stellar J.R. c-Fos and deltaFosB expression are differentially altered in distinct subregions of the nucleus accumbens shell in cocaine-sensitized rats. Neuroscience 137 (2006) 773-780
4. [3H]cocaine in striatum and its relationship to the dopamine transporter. Membrane Biochemistry 7 (1987) 87-106
5. 3 receptor mutants during the development of methamphetamine sensitization. Journal of Neurochemistry 100 (2007) 225-241
6. 2 receptor antagonists given in the acute withdrawal from daily cocaine injections can reverse established sensitization. European Journal of Pharmacology 453 (2002) 255-263
7. 2 receptor-mediated behavior and on extracellular concentrations of serotonin and dopamine. Pharmacology, Biochemistry, and Behavior 49 (1994) 107-113
8. Featherstone R.E., Kapur S., and Fletcher P.J. The amphetamine-induced sensitized state as a model of schizophrenia. Progress in Neuro-psychopharmacology and Biological Psychiatry 31 (2007) 1556-1571
9. 2A/2C receptors in the sensitization to cocaine. Journal of Physiology and Pharmacology 52 (2001) 471-481
10. Fumagalli F., Di Pasquale L., Caffino L., Racagni G., and Riva M.A. Repeated exposure to cocaine differently modulates BDNF mRNA and protein levels in rat striatum and prefrontal cortex. European Journal of Neuroscience 26 (2007) 2756-2763
11. Laruelle M. The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Research Brain Research Reviews 31 (2000) 371-384
12. Li Y., Hu X.T., Berney T.G., Vartanian A.J., Stine C.D., Wolf M.E., and White F.J. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations. Synapse 34 (1999) 169-180
13. Lieberman J.A., Sheitman B.B., and Kinon B.J. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 17 (1997) 205-229
14. Mattingly B.A., Rowlett J.K., Ellison T., and Rase K. Cocaine-induced behavioral sensitization: effects of haloperidol and SCH 23390 treatments. Pharmacology, Biochemistry and Behavior 53 (1996) 481-486
15. McDaid J., Graham M.P., and Napier T.C. Methamphetamine-induced sensitization differentially alters pCREB and DeltaFosB throughout the limbic circuit of the mammalian brain. Molecular Pharmacology 70 (2006) 2064-2074
16. Meng Z.H., Feldpaush D.L., and Merchant K.M. Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats. Brain Research. Molecular Brain Research 61 (1998) 39-50
17. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology 47 Suppl 1 (2004) 24-32
18. Panksepp J. Seeking Systems and Anticipatory States of the Nervous System: Affective Neuroscience (1998), Oxford University Press, Oxford 144-163
19. Pierce R.C., and Kalivas P.W. Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. The Journal of Neuroscience 17 (1997) 3254-3261
20. Pierce R.C., and Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Research. Brain Research Reviews 25 (1997) 192-216
21. Pilotte N.S., Sharpe L.G., and Kuhar M.J. Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats. The Journal of Pharmacology and Experimental Therapeutics 269 (1994) 963-969
22. Post R.M., and Rose H. Increasing effects of repetitive cocaine administration in the rat. Nature 260 (1976) 731-732
23. Pozzi L., Hakansson K., Usiello A., Borgkvist A., Lindskog M., Greengard P., and Fisone G. Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum. Journal of Neurochemistry 86 (2003) 451-459
24. Radwanska K., Caboche J., and Kaczmarek L. Extracellular signal-regulated kinases (ERKs) modulate cocaine-induced gene expression in the mouse amygdala. European Journal of Neuroscience 22 (2005) 939-948
25. Reimer A.R., and Martin-Iverson M.T. Nimodipine and haloperidol attenuate behavioural sensitization to cocaine but only nimodipine blocks the establishment of conditioned locomotion induced by cocaine. Psychopharmacology (Berl) 113 (1994) 404-410
26. Roberts D.C., Zis A.P., and Fibiger H.C. Ascending catecholamine pathways and amphetamine-induced locomotor activity: importance of dopamine and apparent non-involvement of norepinephrine. Brain Research 93 (1975) 441-454
27. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Research Brain Research Reviews 18 (1993) 247-291
28. Roh M.S., Kang U.G., Shin S.Y., Lee Y.H., Jung H.Y., Juhnn Y.S., and Kim Y.S. Biphasic changes in the Ser-9 phosphorylation of glycogen synthase kinase-3beta after electroconvulsive shock in the rat brain. Progress in Neuro-psychopharmacology and Biological Psychiatry 27 (2003) 1-5
29. Ruiu S., Marchese G., Saba P.L., Gessa G.L., and Pani L. The 5-HT2 antagonist ritanserin blocks dopamine re-uptake in the rat frontal cortex. Molecular Psychiatry 5 (2000) 673-677
30. Satel S.L., and Edell W.S. Cocaine-induced paranoia and psychosis proneness. The American Journal of Psychiatry 148 (1991) 1708-1711
31. Sato M., Chen C.C., Akiyama K., and Otsuki S. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biological Psychiatry 18 (1983) 429-440
32. 2high dopamine receptors. Synapse 60 (2006) 319-346
33. Steketee J.D. Cortical mechanisms of cocaine sensitization. Critical Reviews in Neurobiology 17 (2005) 69-86
34. 2 antagonist: an open study. European Neuropsychopharmacology 1 (1991) 101-105
35. Tella S.R. Differential blockade of chronic versus acute effects of intravenous cocaine by dopamine receptor antagonists. Pharmacology, Biochemistry, and Behavior 48 (1994) 151-159
36. Terwilliger R.Z., Beitner-Johnson D., Sevarino K.A., Crain S.M., and Nestler E.J. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Research 548 (1991) 100-110
37. Valjent E., Corvol J.C., Trzaskos J.M., Girault J.A., and Herve D. Role of the ERK pathway in psychostimulant-induced locomotor sensitization. BMC Neuroscience 7 (2006) 20
38. Vanderschuren L.J., and Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 151 (2000) 99-120
39. Wiesbeck G.A., Weijers H.G., Chick J., and Boening J. The effects of ritanserin on mood, sleep, vigilance, clinical impression, and social functioning in alcohol-dependent individuals. Ritanserin in Alcoholism Work Group. Alcohol and Alcoholism 35 (2000) 384-389
40. Yui K., Goto K., Ikemoto S., Ishiguro T., Angrist B., Duncan G.E., Sheitman B.B., Lieberman J.A., Bracha S.H., and Ali S.F. Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization. Molecular Psychiatry 4 (1999) 512-523
41. Zhang X., Mi J., Wetsel W.C., Davidson C., Xiong X., Chen Q., Ellinwood E.H., and Lee T.H. PI3 kinase is involved in cocaine behavioral sensitization and its reversal with brain area specificity. Biochemical and Biophysical Research Communications 340 (2006) 1144-1150
42. Zhang Z.J., Kang W.H., Li Q., Wang X.Y., Yao S.M., and Ma A.Q. Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia: a double-blind, randomized, placebo-controlled study. Schizophrenia Research 88 (2006) 102-110